Travere Therapeutics, Inc. TVTX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s other income, net (note 6)?
- Travere Therapeutics, Inc. (TVTX) reported other income, net (note 6) of -$91K in Q1 2026.
- How has Travere Therapeutics, Inc.'s other income, net (note 6) changed year-over-year?
- Travere Therapeutics, Inc.'s other income, net (note 6) decreased by 116.6% year-over-year, from $549K to -$91K.
- What is the long-term trend for Travere Therapeutics, Inc.'s other income, net (note 6)?
- Over 4 years (2021 to 2025), Travere Therapeutics, Inc.'s other income, net (note 6) has grown at a 166.1% compound annual growth rate (CAGR), from $231K to $11.58M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.